While in the clinical demo expertise with Xyrem in narcolepsy/cataplexy patients at therapeutic doses, two sufferers claimed stress and a single described sleeplessness following abrupt discontinuation on the termination with the clinical trial; in The 2 people with nervousness, the frequency of cat